HB 712: RELATING TO HEALTH.

Session Year: 2025-2026
House: House

Current Status:

Passed

(2025-05-30: Act 143, on 05/30/2025 (Gov. Msg. No. 1243).)

Introduced

First Committee Review

First Chamber

Second Committee Review

Second Chamber

Final Decking

Enacted

Version:

Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

Discussed in Hearing